We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

Sangamo and Pfizer together developed the treatment, called giroctocogene fitelparvovec, and it was licensed to Pfizer. The collaboration and license agreement will terminate on April 21, and Pfizer ...

Sangamo Therapeutics said on Monday it would regain the rights to its hemophilia A gene therapy following the termination of a co-development agreement with partner Pfizer, sending its shares down 30.